TY - JOUR
T1 - Fresh-frozen Plasma as a Source of Exogenous Insulin-like Growth Factor I in the Extremely Preterm Infant.
AU - Pupp, Ingrid
AU - Engström, Eva
AU - Niklasson, Aimon
AU - Berg, Ann-Cathrine
AU - Fellman, Vineta
AU - Löfqvist, Chatarina
AU - Hellström, Ann
AU - Ley, David
PY - 2009
Y1 - 2009
N2 - Context: Preterm birth is followed by a decrease in circulatory levels of IGF-I and IGF binding protein-3 (IGFBP-3), proteins with important neurogenic and angiogenic properties. Objective: To evaluate effects of intravenous administration of fresh frozen plasma (FFP) from adult donors on circulatory levels of IGF-I and IGFBP-3 in extremely preterm infants. Design, setting and patients: A prospective cohort study performed in twenty extremely preterm infants (mean (SD) gestational age 25.3 (1.3) weeks) with clinical requirement of FFP during the first postnatal week. Sampling was performed before initiation of transfusion, directly after and at 6, 12, 24 and 48h after completed FFP transfusion. Main outcome measures: Concentrations of IGF-I and IGFBP-3 before and after transfusion of FFP. Results: FFP with a mean (SD) volume of 11 (3.1) ml/kg, was administered at a postnatal age of median (range) 2 (1-7) days. Mean (SD) IGF-I and IGFBP-3 concentrations in administered FFP were 130 (39) and 2840 (615) microg/L, respectively. Immediately after FFP transfusion, mean (SD) concentrations of IGF-I increased by 133% from 11 (6.4) to 25 (9.3) microg/L, p<0.001 and IGFBP-3 by 61% from 815 (451) to 1311 (508) microg/L, p<0.001. Concentrations of IGF-I and IGFBP-3 remained higher at 6 h, p<0.001, p=0.009 and at 12 h, p=0.017, p=0.018, respectively, as compared to concentrations before FFP transfusion. Typical half-life of administrated IGF-I was 3.4 h for a 1 kg infant. Conclusion: Transfusion of FFP to extremely preterm infants during the first postnatal week elevates levels of IGF-I and IGFBP-3.
AB - Context: Preterm birth is followed by a decrease in circulatory levels of IGF-I and IGF binding protein-3 (IGFBP-3), proteins with important neurogenic and angiogenic properties. Objective: To evaluate effects of intravenous administration of fresh frozen plasma (FFP) from adult donors on circulatory levels of IGF-I and IGFBP-3 in extremely preterm infants. Design, setting and patients: A prospective cohort study performed in twenty extremely preterm infants (mean (SD) gestational age 25.3 (1.3) weeks) with clinical requirement of FFP during the first postnatal week. Sampling was performed before initiation of transfusion, directly after and at 6, 12, 24 and 48h after completed FFP transfusion. Main outcome measures: Concentrations of IGF-I and IGFBP-3 before and after transfusion of FFP. Results: FFP with a mean (SD) volume of 11 (3.1) ml/kg, was administered at a postnatal age of median (range) 2 (1-7) days. Mean (SD) IGF-I and IGFBP-3 concentrations in administered FFP were 130 (39) and 2840 (615) microg/L, respectively. Immediately after FFP transfusion, mean (SD) concentrations of IGF-I increased by 133% from 11 (6.4) to 25 (9.3) microg/L, p<0.001 and IGFBP-3 by 61% from 815 (451) to 1311 (508) microg/L, p<0.001. Concentrations of IGF-I and IGFBP-3 remained higher at 6 h, p<0.001, p=0.009 and at 12 h, p=0.017, p=0.018, respectively, as compared to concentrations before FFP transfusion. Typical half-life of administrated IGF-I was 3.4 h for a 1 kg infant. Conclusion: Transfusion of FFP to extremely preterm infants during the first postnatal week elevates levels of IGF-I and IGFBP-3.
U2 - 10.1210/jc.2008-1293
DO - 10.1210/jc.2008-1293
M3 - Article
C2 - 19001522
SN - 1945-7197
VL - 94
SP - 477
EP - 482
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 2
ER -